What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

3D Printing

PUBLISHER: 360iResearch | PRODUCT CODE: 1611911

PUBLISHER: 360iResearch | PRODUCT CODE: 1611911

3D Printed Drugs Market by Technology (Direct-Write, Fused Deposition Modelling, Inkjet Printing), Dose Form (Capsule, Nanoparticles, Tablet), Application, End-User - Global Forecast 2025-2030

PUBLISHED: December 1, 2024

PAGES: 198 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The 3D Printed Drugs Market was valued at USD 292.72 million in 2023, expected to reach USD 331.22 million in 2024, and is projected to grow at a CAGR of 14.26%, to USD 744.29 million by 2030.

The 3D printed drugs market is an innovative segment in the pharmaceutical industry that aims to revolutionize drug manufacturing by utilizing additive manufacturing techniques to create personalized medication. The need for 3D printed drugs arises from the growing demand for patient-specific medication that can adjust dosages, forms, and compositions to meet individual health requirements effectively. Applications of 3D printed drugs span across chronic disease management, elder care, and pediatrics, where tailored dosages are crucial. The end-use scope includes hospitals, pharmaceutical companies, and research institutions, all seeking efficient, cost-effective, and customized drug production capabilities.

KEY MARKET STATISTICS
Base Year [2023]	USD 292.72 million
Estimated Year [2024]	USD 331.22 million
Forecast Year [2030]	USD 744.29 million
CAGR (%)	14.26%

Key growth factors in this market include technological advancements, the increasing incidence of chronic diseases, and regulatory support from health authorities for personalized medicine. The potential to reduce drug wastage and enhance patient compliance further augments this market's expansion. Opportunities lie in leveraging partnerships with healthcare providers and investing in R&D to develop novel drug formulations that are both efficacious and easy to produce using 3D printing technology. However, challenges such as high initial costs, technical limitations, and stringent regulatory requirements could impede market growth. Additionally, the lack of widespread awareness and acceptance among healthcare providers poses further hurdles.

Innovative research areas with significant potential include developing biocompatible and biodegradable materials for drug printing, enhancing printer speed and precision, and creating a wider array of 3D printed dosage forms. Business growth can be realized by focusing on these technological innovations and fostering strategic alliances that bolster market presence and infrastructure. The nature of the market is dynamic, characterized by rapid technological changes and a growing emphasis on precision medicine. Companies might benefit from developing robust distribution networks and engaging in continuous education initiatives for stakeholders to mitigate limitations and advocate for the integration of 3D printed drugs in mainstream healthcare practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Printed Drugs Market

The 3D Printed Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Surge in demand for instantaneous soluble drugs
- Growing adoption of personalized drugs and the production of combination medicine
- Extensive use of 3D printed technology for manufacturing cancer drugs
Market Restraints
- Material limitations associated with manufacturing of 3D printed drugs
Market Opportunities
- Constant technological developments in 3D printing technique
- Significant investments for manufacturing of 3D printed pharmaceuticals
Market Challenges
- Complexities in manufacturing of 3D printed drugs

Porter's Five Forces: A Strategic Tool for Navigating the 3D Printed Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Printed Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Printed Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Printed Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Printed Drugs Market

A detailed market share analysis in the 3D Printed Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Printed Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Printed Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Printed Drugs Market

A strategic analysis of the 3D Printed Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Printed Drugs Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., 3DR HOLDINGS, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, AstraZeneca plc, BioDuro, LLC, Biomedical Modeling Inc., Cycle Pharmaceuticals, Cyfuse Biomedical K.K., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, GlaxoSmithKline Plc, Materialise NV, Merck KGaA, Organovo Holdings Inc., Proto Labs Inc., Renishaw PLC, Rokit Healthcare Inc., Siemens AG, Stratasys Ltd., Triastek, Inc., TVASTA, Yissum, and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printed Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Technology, market is studied across Direct-Write, Fused Deposition Modelling, Inkjet Printing, Powder Bed Printing, Stereolithography, and Zip Dose.
Based on Dose Form, market is studied across Capsule, Nanoparticles, and Tablet.
Based on Application, market is studied across Dental, Neurology, and Orthopedic.
Based on End-User, market is studied across Clinics & Hospitals, Research Laboratories, and Speciality Clinics.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-431C35F6C179

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Surge in demand for instantaneous soluble drugs
  - 5.1.1.2. Growing adoption of personalized drugs and the production of combination medicine
  - 5.1.1.3. Extensive use of 3D printed technology for manufacturing cancer drugs
- 5.1.2. Restraints
  - 5.1.2.1. Material limitations associated with manufacturing of 3D printed drugs
- 5.1.3. Opportunities
  - 5.1.3.1. Constant technological developments in 3D printing technique
  - 5.1.3.2. Significant investments for manufacturing of 3D printed pharmaceuticals
- 5.1.4. Challenges
  - 5.1.4.1. Complexities in manufacturing of 3D printed drugs
5.2. Market Segmentation Analysis
- 5.2.1. Technology: Direct-write technology provides personalized and effective medication solutions
- 5.2.2. Dose Form: Potential adoption of 3D printed drugs in the form of capsule
- 5.2.3. Application: Proliferating use for manufacturing of neurology drugs
- 5.2.4. End-User: Significant penetration of 3D printed drugs in clinics & hospitals
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. 3D Printed Drugs Market, by Technology

6.1. Introduction
6.2. Direct-Write
6.3. Fused Deposition Modelling
6.4. Inkjet Printing
6.5. Powder Bed Printing
6.6. Stereolithography
6.7. Zip Dose

7. 3D Printed Drugs Market, by Dose Form

7.1. Introduction
7.2. Capsule
7.3. Nanoparticles
7.4. Tablet

8. 3D Printed Drugs Market, by Application

8.1. Introduction
8.2. Dental
8.3. Neurology
8.4. Orthopedic

9. 3D Printed Drugs Market, by End-User

9.1. Introduction
9.2. Clinics & Hospitals
9.3. Research Laboratories
9.4. Speciality Clinics

10. Americas 3D Printed Drugs Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific 3D Printed Drugs Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa 3D Printed Drugs Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Triastek and BioNTech partner to develop 3D printed RNA therapeutics for oral delivery, aiming for over USD 1.2 billion in milestone payments
- 13.3.2. Carcinotech raises GBP 4.2 million for US expansion, enhancing 3D-printed micro-tumour tech for personalized oncology drug development
- 13.3.3. CurifyLabs Launches 3D Printing Solution For Personalised Medicine
- 13.3.4. Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting
- 13.3.5. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. 3D Systems, Inc.
2. 3DR HOLDINGS
3. Anatomics Pty Ltd
4. Aprecia Pharmaceuticals, LLC
5. AstraZeneca plc
6. BioDuro, LLC
7. Biomedical Modeling Inc.
8. Cycle Pharmaceuticals
9. Cyfuse Biomedical K.K.
10. EnvisionTEC GmbH
11. FabRx Ltd.
12. General Electric Company
13. GlaxoSmithKline Plc
14. Materialise NV
15. Merck KGaA
16. Organovo Holdings Inc.
17. Proto Labs Inc.
18. Renishaw PLC
19. Rokit Healthcare Inc.
20. Siemens AG
21. Stratasys Ltd.
22. Triastek, Inc.
23. TVASTA
24. Yissum
25. Zortrax S.A.

Product Code: MRR-431C35F6C179

LIST OF FIGURES

FIGURE 1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
FIGURE 2. 3D PRINTED DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2030 (%)
FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. 3D PRINTED DRUGS MARKET DYNAMICS
TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 41. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 45. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 63. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 67. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 75. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 99. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 112. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 116. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 120. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 124. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 128. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 136. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 148. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 152. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 156. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 172. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 184. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023